Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Home/ Catalogue/ Peptides in Vials/ Melanotan I (Afamelanotide)
In stock
Melanotan I (Afamelanotide)

Melanotan I (Afamelanotide)

Lyophilised · ≥99% (HPLC) ·

Quantity Volume discounts auto-applied
Custom quantity
1

Supplied lyophilised. Reconstitution typically uses bacteriostatic water.

Independently third-party tested · COA on every batch · 48h EU dispatch
[01]

Overview

Melanotan I (Afamelanotide) is a synthetic tridecapeptide analogue of α-melanocyte-stimulating hormone (α-MSH), with the sequence Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂; CAS 75921-69-6; molecular weight 1646.87 g/mol; supplied lyophilised at ≥99% purity by HPLC. A potent, long-acting MC1R agonist studied in photoprotection, melanogenesis and pigmentation models. For laboratory research use only; not for human or veterinary use.

The pigment system that protects skin from light is governed by a single hormone — and a synthetic analog of it has become one of the best-characterized melanocortin peptides in research. Melanotan I, known generically as afamelanotide, is a synthetic 13-amino-acid analog of α-melanocyte-stimulating hormone (α-MSH), formally [Nle⁴,D-Phe⁷]-α-MSH. Substituting two residues in the native sequence yields a more stable, longer-acting agonist of the melanocortin-1 receptor (MC1R), making it a valuable tool for studying pigmentation and photoprotection biology.

A more durable version of a natural signal. Native α-MSH is rapidly degraded, limiting its experimental utility. The norleucine-4 and D-phenylalanine-7 substitutions in afamelanotide confer resistance to enzymatic breakdown and enhanced receptor affinity, prolonging MC1R activation and the downstream synthesis of eumelanin (Minder et al., 2017). This pharmacology has positioned afamelanotide as a reference compound in melanocortin research and as the subject of sustained clinical investigation.

What the research explores. The literature concentrates on pigmentation and photoprotective endpoints:

  • Photoprotection mechanisms — reviews describe how MC1R-driven eumelanin synthesis underlies afamelanotide's role in reducing phototoxicity (Wensink et al., 2021; Lane et al., 2016).
  • Erythropoietic protoporphyria models — extensive clinical and observational research has characterized light tolerance and quality-of-life endpoints in EPP (Kim et al., 2016; Homey et al., 2025).
  • Broader dermatologic applications — analyses explore the peptide's potential reach across additional skin conditions (Wu et al., 2021; Polańska et al., 2024).

These findings derive from clinical, observational, and laboratory research describing biological activity; they are presented for scientific context and do not constitute human use guidance from this listing. Full citations are listed under the Scientific References tab.

Physicochemical profile. CAS 75921-69-6 · Molecular formula C₇₈H₁₁₁N₂₁O₁₉ · Molecular weight 1646.8 g/mol · Sequence Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂ · Appearance: white lyophilized powder · Soluble in water.

Specification & quality. Each individually sealed vial contains 10 mg of Melanotan I (afamelanotide) as a white lyophilized powder at ≥99% purity by HPLC. Every batch is third-party tested, with a Certificate of Analysis (COA) available. Store at −20 °C, protected from light and moisture.

This product is intended for laboratory research use only (RUO). It is not a drug, food, cosmetic, or dietary supplement, and is not for human or veterinary use, ingestion, or diagnostic application. Handling is restricted to qualified research professionals operating in an appropriately equipped laboratory.

Supplied for in-vitro laboratory research use only (RUO). Not a drug, food or supplement; not for human or veterinary use.

[04]

Quality & COA

Certificate of Analysis
Lot-specific COA with every order

Certificate of Analysis — lot-specific COA ships with every order and is available on request.

Each lot is tested by an independent third-party laboratory for identity (mass spectrometry) and purity (HPLC). The Certificate of Analysis for your specific batch ships with the order and is available on request — no house data, no exceptions.

HPLC purity
≥99% (HPLC)
Method
HPLC + MS
Endotoxin
Reported
[02]

Data Sheet

CAS number75921-69-6
Molecular formulaC₇₈H₁₁₁N₂₁O₁₉
Molecular weight1646.8
SequenceAc-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂
Purity≥99% (HPLC)
Physical formWhite lyophilized powder
Quantity10mg/vial
SolubilitySoluble in water
StorageStore at -20°C, protect from light
Shelf life24 months from manufacture date
OriginEU · Slovakia
ClassificationResearch use only
[03]

Scientific References

01 Polańska A, Wegner J, Nutbohm P et al.. Afamelanotide in protoporphyria and other skin diseases: a review. Postepy Dermatol Alergol. 2024. PMID: 38784937. doi:10.5114/ada.2024.138818. PubMed 02 Wu J, Cotliar R. Afamelanotide: An Orphan Drug with Potential for Broad Dermatologic Applications. J Drugs Dermatol. 2021. PMID: 33683075. doi:10.36849/JDD.5526. PubMed 03 Wensink D, Wagenmakers MAEM, Langendonk JG. Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria. Expert Rev Clin Pharmacol. 2021. PMID: 33507118. doi:10.1080/17512433.2021.1879638. PubMed 04 Minder EI, Barman-Aksoezen J, Schneider-Yin X. Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders. Clin Pharmacokinet. 2017. PMID: 28063031. doi:10.1007/s40262-016-0501-5. PubMed 05 Lane AM, McKay JT, Bonkovsky HL. Advances in the management of erythropoietic protoporphyria - role of afamelanotide. Appl Clin Genet. 2016. PMID: 28003770. doi:10.2147/TACG.S122030. PubMed 06 Kim ES, Garnock-Jones KP. Afamelanotide: A Review in Erythropoietic Protoporphyria. Am J Clin Dermatol. 2016. PMID: 26979527. doi:10.1007/s40257-016-0184-6. PubMed 07 Minder EI, Schneider-Yin X. Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria. Expert Rev Clin Pharmacol. 2015. PMID: 25470471. doi:10.1586/17512433.2014.956089. PubMed 08 Fabrikant J, Touloei K, Brown SM. A review and update on melanocyte stimulating hormone therapy: afamelanotide. J Drugs Dermatol. 2013. PMID: 23884489. PubMed 09 . Afamelanotide. . 2012. PMID: 38598652. PubMed 10 Minder EI. Afamelanotide, an agonistic analog of α-melanocyte-stimulating hormone, in dermal phototoxicity of erythropoietic protoporphyria. Expert Opin Investig Drugs. 2010. PMID: 21073357. doi:10.1517/13543784.2010.535515. PubMed 11 Chawathe A, Sharma N. Investigation of the stability profile of therapeutic α-MSH analogue: Insights from liquid chromatography-high resolution mass spectrometry analysis of afamelanotide. J Pharm Biomed Anal. 2026. PMID: 41547183. doi:10.1016/j.jpba.2026.117362. PubMed 12 Seidl-Philipp M, Schratter H, Auer J et al.. Afamelanotide improves quality of life and light tolerance in Austrian erythropoietic protoporphyria patients. J Dtsch Dermatol Ges. 2026. PMID: 41793078. doi:10.1111/ddg.15996. PubMed 13 Minder AE, Barman-Aksözen J. From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria. JAAD Case Rep. 2026. PMID: 41542313. doi:10.1016/j.jdcr.2025.11.022. PubMed 14 Dawe RS, Kerr A, Eadie E et al.. Afamelanotide in managing cutaneous phototoxicity in erythropoietic protoporphyria: a Scottish perspective. Clin Exp Dermatol. 2025. PMID: 40692281. doi:10.1093/ced/llaf306. PubMed 15 Homey B, Schelonke K, Schlegel CM et al.. German Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP). Photodermatol Photoimmunol Photomed. 2025. PMID: 40082741. doi:10.1111/phpp.13012. PubMed

References are illustrative of the research literature surrounding this compound. All claims relate to in-vitro and animal models only.

[05]

FAQ

Melanotan I, also called Afamelanotide, is a synthetic linear 13-amino-acid analogue of α-melanocyte-stimulating hormone — [Nle4,D-Phe7]-α-MSH (Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2). It is one of the best-characterized melanocortin peptides in pigmentation research. Condor Research supplies it as a 10 mg lyophilized vial at ≥99% HPLC purity, for in-vitro laboratory use only.

They are distinct molecules. Melanotan I (Afamelanotide) is a linear 13-residue α-MSH analogue, while Melanotan II is a smaller cyclic heptapeptide. Melanotan I more closely resembles native α-MSH and is studied as a more receptor-faithful pigmentation tool, whereas Melanotan II is a non-selective melanocortin agonist. Condor Research offers each as a separate ≥99% HPLC, research-use-only reference compound.

Melanotan I is a linear 13-amino-acid peptide built on the α-MSH backbone, whereas Melanotan II is a constrained cyclic heptapeptide. The cyclization in Melanotan II broadens its melanocortin-receptor activity, while Melanotan I's linear structure stays closer to the natural hormone. Researchers choose between them by receptor profile. Both are research-use-only reference materials, never for human use.

Melanotan I is a linear α-MSH analogue studied in skin and pigmentation research, while PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin analogue investigated in different research contexts. Both belong to the melanocortin family but differ in structure and receptor emphasis. Condor Research supplies each as a separate ≥99% HPLC, research-use-only reference compound with its own batch COA.

Melanotan I (Afamelanotide) is selected when a research model calls for a linear α-MSH analogue that stays close to the native hormone's structure, rather than the broader, non-selective activity of cyclic Melanotan II. The choice depends entirely on the receptor profile required by your in-vitro study. Both remain research-use-only reference materials with no human application.

Melanotan I is a full 13-residue α-MSH analogue spanning the hormone's active core, while KPV is just the three C-terminal residues (Lys-Pro-Val) of α-MSH, studied mainly for anti-inflammatory research rather than pigmentation. One models the broad melanocortin signal; the other an isolated fragment. Both are offered as separate ≥99% HPLC, research-use-only reference compounds.

Yes. Melanotan I is supplied strictly for laboratory research use only (in vitro). It is not a medicine, food, supplement, cosmetic, or medical device, and is not for human or veterinary use, administration, or consumption. Condor Research provides no dosing, protocols, or human-use guidance. Purchase is limited to qualified professionals and institutions aged 18 or over.

Yes. Each lot is verified as Melanotan I (Afamelanotide), CAS 75921-69-6, by an independent third-party laboratory using HPLC for purity and mass spectrometry for identity, distinguishing it clearly from the cyclic Melanotan II. It ships against a batch-specific Certificate of Analysis confirming ≥99% purity, available on request at info@condorresearch.com.

Condor Research ships from the EU with sanctions and export screening before dispatch, and does not ship to restricted territories. Whether a specific compound can be imported into your country is your responsibility to verify, and some destinations may have product-specific restrictions. For confirmation on your destination, contact info@condorresearch.com before ordering.

For analytical laboratory preparation only, Melanotan I is water-soluble and can be reconstituted with a sterile aqueous diluent; the chosen volume sets the working concentration. As a melanocortin peptide, store the sealed lyophilized vial at -20°C, protected from light, with a 24-month shelf life. This is laboratory handling information, not guidance for any human or animal use.

[06]

Reviews

Leave a review
Earn 250 points for a verified review (account required).
4.7
68 verified reviews
5
78%
4
16%
3
4%
2
1%
1
0%
Apr 2026
Impeccable packaging

Cold-chain handling was respected end to end. Vials arrived sealed, labelled and intact. Documentation is the most thorough I've seen from an EU supplier.

Dr. S. Novak · Private lab · CZ Verified purchase
Mar 2026
Reliable, well documented

Solubility and stability were as described. Knocked one star only because express shipping options are limited, but quality is not in question.

P. Andersson · Research institute · SE Verified purchase
Mar 2026
Reproducible across batches

Third order with Condor. Batch-to-batch variation is minimal, which matters for our longitudinal work. The mono-labelled vials are easy to track.

Dr. R. Costa · Academic lab · PT Verified purchase
Feb 2026
Exactly what research needs

No marketing fluff — just characterised material with paperwork. The data sheet and CAS matched our records precisely.

J. Meijer · Biotech R&D · NL Verified purchase

Related compounds